HOME >> BIOLOGY >> NEWS
Plant-like enzyme acts as key life cycle switch in malaria parasite

An essential switch in the life cycle of the malaria parasite has been uncovered by researchers in England, Germany and Holland.

They have established that to infect mosquitoes that transmit malaria, the parasites depend on a type of molecule normally found in plants, which they have named Calcium-Dependent Protein Kinase 4 (CDPK4).

The finding, based on studies of the malaria parasite of rodents, Plasmodium berghei, is described as basic science, but the authors suggest it may give drug researchers a specific and safe target against which to screen potential anti-malarial drug compounds.

The findings are reported in today's edition of the journal Cell (14 May) by researchers from Imperial College London, Leiden University Medical Center, Netherlands, and the Max-Planck Institute of Infection Biology, Germany.

"This work identifies the first signalling molecule that we know is essential for the transmission of the parasite," says Dr Oliver Billker, research fellow and lead author, from Imperial College London.

"It is an essential molecule because if the malaria parasite doesn't have this gene function then transmission of the parasite to mosquitoes is completely disrupted. It is also specific to development of the male gametes only."

"CDPK4 is unusual because apart from the malaria parasite and some other single-celled organisms, it is only seen in plants. This makes it appealing as a target for drug developers, who would not run such a big risk of developing a drug with strong side effects, because CDPK4-like molecules do not exist in humans."

The human malaria parasite has two hosts, humans and mosquitoes. Just after the mosquito has taken a blood meal from a human, malaria parasites in the mosquito bloodstream differentiate into male and female sexual forms, named micro- and macro-gametes respectively.

In 1997, Imperial College researchers discovered that the mosquito molecule xanthurenic acid
'"/>

Contact: Tom Miller
t.miller@imperial.ac.uk
44-207-594-6704
Imperial College London
13-May-2004


Page: 1 2

Related biology news :

1. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
2. First glimpse of DNA binding to viral enzyme
3. Two enzymes key to calorie-burning, Brown research shows
4. Argonne scientists determine structure of staph, anthrax enzyme
5. Brain serotonin enzyme finding might explain psychiatric disorders
6. Study finds plant enzyme function changes with location in cell
7. Basic RNA enzyme research promises single-molecule biosensors
8. Molecule that blocks key bacterial enzyme may lead to new antibiotics
9. Study finds first evidence COX-2 enzymes can regulate DNA damage
10. UNC scientists block cellular enzyme activity involved in cancer progression
11. ADAM: Good enzyme for Alzheimer disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
(Date:6/25/2020)... (PRWEB) , ... June 24, 2020 , ... ... cloud-based enterprise software and software-driven clinical data services that accelerate drug development, is ... low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... today announced that the launch of a new clinical diagnostics immuno-oncology ... the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids ...
Breaking Biology Technology:
Cached News: